NAUT NAUTILUS BIOTECHNOLOGY INC revenue, earnings and financials
For the quarter ended June 30, 2026, NAUTILUS BIOTECHNOLOGY INC reported revenue of $190K, net income of −$14.5M and diluted EPS of −$0.11; for the fiscal year ended December 2025 revenue was n/a.
NAUT annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income n/a, net income −$59.0M (margin n/a), EPS −$0.47
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income n/a, net income −$70.8M (margin n/a), EPS −$0.56
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income n/a, net income −$63.7M (margin n/a), EPS −$0.51
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income n/a, net income −$57.9M (margin n/a), EPS −$0.46
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income n/a, net income −$50.3M (margin n/a), EPS −$0.60
NAUT quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $190K, net income −$14.5M, EPS −$0.11
- Quarter ended Mar 31, 2026: revenue n/a, net income −$14.7M, EPS −$0.12
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$13.8M, EPS −$0.11
- Quarter ended Sep 30, 2025: revenue n/a, net income −$13.6M, EPS −$0.11
- Quarter ended Jun 30, 2025: revenue $0, net income −$15.0M, EPS −$0.12
- Quarter ended Mar 31, 2025: revenue n/a, net income −$16.6M, EPS −$0.13
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$17.6M, EPS −$0.14
- Quarter ended Sep 30, 2024: revenue n/a, net income −$16.4M, EPS −$0.13
- Quarter ended Jun 30, 2024: revenue n/a, net income −$18.0M, EPS −$0.14
- Quarter ended Mar 31, 2024: revenue n/a, net income −$18.7M, EPS −$0.15
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$17.0M, EPS −$0.13
- Quarter ended Sep 30, 2023: revenue n/a, net income −$15.9M, EPS −$0.13
- Quarter ended Jun 30, 2023: revenue n/a, net income −$15.8M, EPS −$0.13
- Quarter ended Mar 31, 2023: revenue n/a, net income −$15.0M, EPS −$0.12
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$13.4M, EPS −$0.10
- Quarter ended Sep 30, 2022: revenue n/a, net income −$14.1M, EPS −$0.11
- Quarter ended Jun 30, 2022: revenue n/a, net income −$14.7M, EPS −$0.12
- Quarter ended Mar 31, 2022: revenue n/a, net income −$15.8M, EPS −$0.13
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$16.7M, EPS −$0.04
- Quarter ended Sep 30, 2021: revenue n/a, net income −$14.5M, EPS −$0.12
NAUT cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$50.7M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$59.1M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$51.7M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$45.8M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$39.2M, share buybacks n/a
NAUT balance sheet
- Jun 30, 2026: cash $13.2M, total assets $164M, total liabilities $32.5M, shareholders' equity $131M
- Mar 31, 2026: cash $14.6M, total assets $178M, total liabilities $33.4M, shareholders' equity $144M
- Dec 31, 2025: cash $12.4M, total assets $191M, total liabilities $34.1M, shareholders' equity $157M
- Sep 30, 2025: cash $23.9M, total assets $201M, total liabilities $31.8M, shareholders' equity $169M
- Jun 30, 2025: cash $34.5M, total assets $213M, total liabilities $32.1M, shareholders' equity $181M
- Mar 31, 2025: cash $33.2M, total assets $228M, total liabilities $33.3M, shareholders' equity $194M
- Dec 31, 2024: cash $27.6M, total assets $243M, total liabilities $34.0M, shareholders' equity $209M
- Sep 30, 2024: cash $4.41M, total assets $260M, total liabilities $36.3M, shareholders' equity $223M
Is NAUT profitable?
No. NAUTILUS BIOTECHNOLOGY INC lost $56.5M over the last four quarters.
What is NAUT's EPS?
Diluted earnings per share over the last four quarters were −$0.45; −$0.11 in the latest quarter.